Cargando…
Identification of Barriers Preventing Biosimiliar Oncology Medication Adoption
(1) Background: A biosimilar is a biologic medical product that has been approved by the United States Food and Federal Drug Administration (FDA) and is an almost identical copy of an original biologic product yet manufactured by a different company. Biosimilars are often assumed to be the same as g...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696566/ https://www.ncbi.nlm.nih.gov/pubmed/36363490 http://dx.doi.org/10.3390/medicina58111533 |